Skip to main content

Glenview Trust Co

SEC CIK
0001691827
Latest filing
Aug 18, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Glenview Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2025
Holdings of HALO by Glenview Trust Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−3,740−100.0%Sold outHolders
Q3 20253,740$274.3K<0.1%+3,740NewHolders